FDA Form 483 explained: responding to findings and managing regulatory risk

The article explains the significance of FDA Form 483 following inspections, emphasizing the critical 15-business-day response window, the importance of patient risk assessments, and how companies can effectively manage regulatory risk by responding to observations, including when disputes arise.

This Wire brief sits within Fusion42's coverage of Biotech.